Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 124.09 | N/A |
| PEG Ratio (TTM) | -1.75 | N/A |
| P/S Ratio (TTM) | 5.07 | N/A |
| P/B Ratio (TTM) | 2.89 | N/A |
| P/FCF Ratio (TTM) | 15.63 | N/A |
| Price to 5YR AVG Earnings Ratio | 25.21 | N/A |
| Price to 5YR AVG FCF Ratio | 16.89 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.43% | N/A |
| ROE (TTM) | 2.30% | N/A |
| Net Profit Margin (TTM) | 4.04% | N/A |
| ROIC 5YR AVG | 17.09% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2,404.86% | 569.17% | 332.07% |
| Revenue | 0.78% | -10.63% | 5.30% |
| Net Income | 2,603.01% | 646.52% | 378.79% |
| Cash Flow | 615.19% | 89.41% | 45.65% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.68 | N/A |
| Quick Ratio (TTM) | 1.68 | N/A |
| D/E Ratio (TTM) | 0.21 | N/A |
| Interest Coverage (TTM) | 7.21 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 3.86 | N/A |
| LTL to 5YR AVG FCF | 0.01 | N/A |
| Shares Outstanding Growth 5YR AVG | 31.41% | N/A |